These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38760864)

  • 1. Strengthening regional commitment to ensuring access to medical abortion medicines in WHO's South-East Asia region: report of a participatory assessment and workshop.
    Upadhyay MT; Fusire T; Loi UR; Sorhaindo A; Salahuddin M; Hossain MA; Tshomo T; Mulati E; Daisy L; Anggraweni DP; Gultom T; Indrawati F; Jenyfa M; Than MM; Bhattarai B; Moonasinghe L; Mathota C; Jitruknatee A; Cham C; Ganatra B; Raina N
    Reprod Health; 2024 May; 20(Suppl 1):191. PubMed ID: 38760864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
    Grossman A; Prata N; Williams N; Ganatra B; Lavelanet A; Läser L; Asmani C; Elamin H; Ouedraogo L; Rahman MM; Conneh-Duworko MJ; Tehoungue BZ; Chanza H; Phiri H; Bhattarai B; Dhakal NP; Ojo OA; Afolabi K; Kabuteni TJ; Hailu BG; Moses F; Dlamini-Nqeketo S; Zulu T; Rehnström Loi U
    Reprod Health; 2023 Apr; 20(Suppl 1):58. PubMed ID: 37041543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
    Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
    Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape assessment of the availability of medical abortion medicines in India.
    Karna P; Sharma KA; Grossman A; Gupta M; Chatterjee T; Williams N; Prata N; Sorhaindo A; Läser L; Rehnström Loi U; Ganatra B; Chaudhary P
    Reprod Health; 2024 Jun; 20(Suppl 1):193. PubMed ID: 38840263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
    Rehnström Loi U; Prata N; Grossman A; Lavelanet A; Williams N; Ganatra B
    Reprod Health; 2023 Jan; 20(Suppl 1):20. PubMed ID: 36694182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
    Chivukula MV; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortion service provision in South Asia: A comparative study of four countries.
    Singh S; Sundaram A; Hossain A; Puri MC; Sathar Z; Shekhar C; Crowell M; Moore AM
    Contraception; 2020 Sep; 102(3):210-219. PubMed ID: 32479764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation.
    Perehudoff K; Berro Pizzarossa L; Stekelenburg J
    BMC Int Health Hum Rights; 2018 Feb; 18(1):8. PubMed ID: 29390996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region.
    Chivukula MV; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):62-66. PubMed ID: 30136662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries.
    Briggs J; Embrey M; Maliqi B; Hedman L; Requejo J
    BMC Health Serv Res; 2018 Dec; 18(1):952. PubMed ID: 30526593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmonizing national abortion and pregnancy prevention laws and policies for sexual violence survivors with the Maputo Protocol: proceedings of a 2016 regional technical meeting in sub-Saharan Africa.
    Thompson J; Undie CC; Amin A; Johnson BR; Khosla R; Ouedraogo L; Nkurunziza T; Rich S; Westley E; Garcia M; Birungi H; Askew I
    BMC Proc; 2018; 12(Suppl 5):5. PubMed ID: 30044888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating implementation of the World Health Organization's Strategic Approach to strengthening sexual and reproductive health policies and programs to address unintended pregnancy and unsafe abortion.
    Rashid S; Moore JE; Timmings C; Vogel JP; Ganatra B; Khan DN; Sayal R; Metin Gülmezoglu A; Straus SE
    Reprod Health; 2017 Nov; 14(1):153. PubMed ID: 29157274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive rights: an international sample.
    Boyd S
    Conscience; 1984; 5(3):13-4. PubMed ID: 12178930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.
    Grundy Q; Parker L; Wong A; Fusire T; Dimancesco D; Tisocki K; Walkowiak H; Vian T; Kohler J
    Global Health; 2022 Mar; 18(1):33. PubMed ID: 35303902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to pain relief and essential opioids in the WHO South-East Asia Region: challenges in implementing drug reforms.
    Vallath N; Rajagopal MR; Perera S; Khan F; Paudel BD; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):67-72. PubMed ID: 30136663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya.
    Perehudoff K; Kibira D; Wuyts E; Pericas C; Omwoha J; van den Ham HA; Mantel-Teeuwisse AK; Michielsen K
    Reprod Health; 2022 Feb; 19(1):37. PubMed ID: 35130932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory standards and processes for over-the-counter availability of hormonal contraception and drugs for medical abortion in five countries in the Eastern Mediterranean Region.
    Ammerdorffer A; Laws M; Awiligwe A; Erb F; Im-Amornphong W; Gülmezoglu AM; Chinery L; Lucido B; Narasimhan M
    Health Res Policy Syst; 2021 Apr; 19(Suppl 1):51. PubMed ID: 33882941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.